SearchDictionaryMobileLogin

Irshad H Chaudry Selected Research

Hemorrhage

10/2008Selective inhibition of iNOS attenuates trauma-hemorrhage/resuscitation-induced hepatic injury.
10/2008Mechanism of estrogen-mediated improvement in cardiac function after trauma-hemorrhage: p38-dependent normalization of cardiac Akt phosphorylation and glycogen levels.
08/2008The role of MIP-1alpha in the development of systemic inflammatory response and organ injury following trauma hemorrhage.
08/2008Flutamide protects against trauma-hemorrhage-induced liver injury via attenuation of the inflammatory response, oxidative stress, and apopotosis.
08/2008Estrogen ameliorates trauma-hemorrhage-induced lung injury via endothelial nitric oxide synthase-dependent activation of protein kinase G.
07/2008Sex steroids/receptor antagonist: their use as adjuncts after trauma-hemorrhage for improving immune/cardiovascular responses and for decreasing mortality from subsequent sepsis.
07/2008The role of estrogen receptor subtypes on hepatic neutrophil accumulation following trauma-hemorrhage: Direct modulation of CINC-1 production by Kupffer cells.
06/2008Mechanism of estrogen-mediated intestinal protection following trauma-hemorrhage: p38 MAPK-dependent upregulation of HO-1.
06/2008p38 MAPK-dependent eNOS upregulation is critical for 17beta-estradiol-mediated cardioprotection following trauma-hemorrhage.
04/2008Mitogen activated protein kinase (MAPK) mediates non-genomic pathway of estrogen on T cell cytokine production following trauma-hemorrhage.
03/200817beta-Estradiol: a novel hormone for improving immune and cardiovascular responses following trauma-hemorrhage.
03/2008Estrogen: a novel therapeutic adjunct for the treatment of trauma-hemorrhage-induced immunological alterations.
03/2008Trauma-hemorrhage inhibits splenic dendritic cell proinflammatory cytokine production via a mitogen-activated protein kinase process.
03/2008Estrogen-mediated activation of non-genomic pathway improves macrophages cytokine production following trauma-hemorrhage.
01/200817beta-Estradiol's salutary effects on splenic dendritic cell functions following trauma-hemorrhage are mediated via estrogen receptor-alpha.
10/2007Mechanism of estrogen-mediated attenuation of hepatic injury following trauma-hemorrhage: Akt-dependent HO-1 up-regulation.
09/2007Mechanism of the nongenomic effects of estrogen on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of the PI-3K/Akt pathway.
09/2007Estrogen receptor-alpha predominantly mediates the salutary effects of 17beta-estradiol on splenic macrophages following trauma-hemorrhage.
07/200717 Beta-estradiol normalizes Toll receptor 4, mitogen activated protein kinases and inflammatory response in epidermal keratinocytes following trauma-hemorrhage.
06/2007Salutary effects of 17beta-estradiol on T-cell signaling and cytokine production after trauma-hemorrhage are mediated primarily via estrogen receptor-alpha.
06/2007The PI3K/Akt pathway mediates the nongenomic cardioprotective effects of estrogen following trauma-hemorrhage.
06/2007The role of estrogen receptor subtypes in ameliorating hepatic injury following trauma-hemorrhage.
06/2007Role of p38 mitogen-activated protein kinase pathway in estrogen-mediated cardioprotection following trauma-hemorrhage.
05/2007Downregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhage.
05/2007Downregulation of TLR4-dependent ATP production is critical for estrogen-mediated immunoprotection in Kupffer cells following trauma-hemorrhage.
04/2007G protein-coupled receptor 30-dependent protein kinase A pathway is critical in nongenomic effects of estrogen in attenuating liver injury after trauma-hemorrhage.
04/2007The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels.
03/2007Androstenediol inhibits the trauma-hemorrhage-induced increase in caspase-3 by downregulating the inducible nitric oxide synthase pathway.
03/2007Monocyte chemoattractant protein-1 influences trauma-hemorrhage-induced distal organ damage via regulation of keratinocyte-derived chemokine production.
03/200717Beta-estradiol downregulates Kupffer cell TLR4-dependent p38 MAPK pathway and normalizes inflammatory cytokine production following trauma-hemorrhage.
03/2007Anti-rat soluble IL-6 receptor antibody down-regulates cardiac IL-6 and improves cardiac function following trauma-hemorrhage.
03/2007The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage.
02/2007Flutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathway.
01/2007Tissue compartment-specific role of estrogen receptor subtypes in immune cell cytokine production following trauma-hemorrhage.
01/200717beta-Estradiol modulates vasoconstriction induced by endothelin-1 following trauma-hemorrhage.
01/2007Young and middle-age associated differences in cytokeratin expression after bone fracture, tissue trauma, and hemorrhage.
01/2007Liver cytokine production and ICAM-1 expression following bone fracture, tissue trauma, and hemorrhage in middle-aged mice.
11/2006Effects of 17beta-estradiol and flutamide on splenic macrophages and splenocytes after trauma-hemorrhage.
11/2006Lidocaine depresses splenocyte immune functions following trauma-hemorrhage in mice.
10/2006Effects of 17beta-estradiol and flutamide on inflammatory response and distant organ damage following trauma-hemorrhage in metestrus females.
09/2006Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage.
09/2006Maintenance of lung myeloperoxidase activity in proestrus females after trauma-hemorrhage: upregulation of heme oxygenase-1.
08/200617 beta-estradiol administration following trauma-hemorrhage prevents the increase in Kupffer cell cytokine production and MAPK activation predominately via estrogen receptor-alpha.
08/2006Androstenediol administration after trauma-hemorrhage attenuates inflammatory response, reduces organ damage, and improves survival following sepsis.
07/2006A role of PPAR-gamma in androstenediol-mediated salutary effects on cardiac function following trauma-hemorrhage.
06/2006Inhibition of cardiac PGC-1alpha expression abolishes ERbeta agonist-mediated cardioprotection following trauma-hemorrhage.
06/2006Are the protective effects of 17beta-estradiol on splenic macrophages and splenocytes after trauma-hemorrhage mediated via estrogen-receptor (ER)-alpha or ER-beta?
05/2006Tissue-specific expression of estrogen receptors and their role in the regulation of neutrophil infiltration in various organs following trauma-hemorrhage.
05/2006Salutary effects of estrogen receptor-beta agonist on lung injury after trauma-hemorrhage.
04/2006Androstenediol ameliorates alterations in immune cells cytokine production capacity in a two-hit model of trauma-hemorrhage and sepsis.
03/2006Estradiol improves cardiac and hepatic function after trauma-hemorrhage: role of enhanced heat shock protein expression.
02/2006Mechanism of the salutary effects of flutamide on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of estrogen receptor-{beta}-dependent HO-1.
01/2006Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1.
12/2005PGC-1 upregulation via estrogen receptors: a common mechanism of salutary effects of estrogen and flutamide on heart function after trauma-hemorrhage.
08/2005Salutary effects of androstenediol on hepatic function after trauma-hemorrhage are mediated via peroxisome proliferators-activated receptor gamma.
07/2005Mechanism of salutary effects of estradiol on organ function after trauma-hemorrhage: upregulation of heme oxygenase.
05/2005Transgenic prolactin-/- mice: effect of trauma-hemorrhage on splenocyte functions.
05/2005Gender differences in small intestinal perfusion following trauma hemorrhage: the role of endothelin-1.
02/2005Mechanism of salutary effects of androstenediol on hepatic function after trauma-hemorrhage: role of endothelial and inducible nitric oxide synthase.
11/2004Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-alpha.
11/2004Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function.
09/2004Estradiol's effect on portal response to endothelin-1 after trauma-hemorrhage.
08/2004The effect of inhibition of a major cell signaling pathway following trauma hemorrhage on hepatic injury and interleukin 6 levels.
08/2004Salutary effects of androstenediol on cardiac function and splanchnic perfusion after trauma-hemorrhage.
06/2004Role of IL-10 in regulating proinflammatory cytokine release by Kupffer cells following trauma-hemorrhage.
05/2004The role of interleukin-10 in the regulation of the systemic inflammatory response following trauma-hemorrhage.
02/2004Physiological levels of 5 alpha-dihydrotestosterone depress wound immune function and impair wound healing following trauma-hemorrhage.
12/2003Upregulation of hepatic prolactin receptor gene expression by 17beta-estradiol following trauma-hemorrhage.
08/2003Immunomodulatory effects of dehydroepiandrosterone in proestrus female mice after trauma-hemorrhage.
07/2003Sex-specific p38 MAP kinase activation following trauma-hemorrhage: involvement of testosterone and estradiol.
06/2003Gender dimorphic tissue perfusion response after acute hemorrhage and resuscitation: role of vascular endothelial cell function.
04/2003Effect of estradiol administration on splanchnic perfusion after trauma-hemorrhage and sepsis.
03/2003Immunoprotection in proestrus females following trauma-hemorrhage: the pivotal role of estrogen receptors.
10/2002Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-kappaB and MAPK/ERK mechanisms.
04/2002Preservation of splenic immune functions by female sex hormones after trauma-hemorrhage.
01/2002Estradiol administration improves splanchnic perfusion following trauma-hemorrhage and sepsis.
01/2002L-arginine: a unique amino acid for improving depressed wound immune function following hemorrhage.
01/2002Female sex hormones regulate macrophage function after trauma-hemorrhage and prevent increased death rate from subsequent sepsis.

Articles by Research Topic

Disease

87Wounds and Injuries (Trauma)
10/2008 - 01/2002
78Hemorrhage
10/2008 - 01/2002
13Sepsis (Septicemia)
07/2008 - 01/2002
6Burns
05/2008 - 02/2005
6Hemorrhagic Shock
01/2006 - 06/2003
4Poisoning
05/2008 - 08/2006
2Bone Fractures (Bone Fracture)
01/2007 - 01/2007
2Anoxia (Hypoxia)
09/2006 - 05/2002
2Shock
01/2006 - 01/2004
1Multiple Organ Failure (MODS)
02/2007
1Multiple Trauma (Multiple Injuries)
02/2007
1Edema
05/2005
1Insulin Resistance
11/2004
1Brain Death (Brain Dead)
12/2003

Drug/Important Bio-Agent (IBA)

21Estrogens (Estrogen)FDA Link
10/2008 - 05/2002
10Estradiol (Estrace)FDA LinkGeneric
06/2008 - 01/2002
8Flutamide (Eulexin)FDA LinkGeneric
08/2008 - 07/2005
7AndrostenediolIBA
03/2007 - 08/2004
5p38 Mitogen-Activated Protein KinasesIBA
06/2008 - 07/2003
5Interleukin-6 (Interleukin 6)IBA
03/2007 - 08/2004
5Estrogen Receptor betaIBA
09/2006 - 01/2006
4Estrogen Receptor alphaIBA
01/2008 - 08/2006
4Gonadal Steroid Hormones (Sex Hormones)IBA
09/2007 - 01/2002
4Peroxidase (Myeloperoxidase)IBA
09/2007 - 05/2005
4Estrogen ReceptorsIBA
05/2006 - 03/2003
3SteroidsIBA
07/2008 - 01/2004
3Protein Kinases (Protein Kinase)IBA
04/2008 - 06/2007
3Endothelin-1 (Endothelin 1)IBA
01/2007 - 09/2004
3CorticosteroneIBA
12/2006 - 07/2005
3AdrenomedullinIBA
11/2002 - 04/2002
2Heme Oxygenase-1IBA
05/2008 - 09/2006
2Adenosine Triphosphate (ATP)IBA
05/2007 - 01/2004
2Toll-Like Receptors (Toll-Like Receptor)IBA
03/2007 - 10/2005
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2007 - 02/2005
2Interleukin-18 (Interleukin 18)IBA
08/2006 - 05/2005
2Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2006 - 01/2006
2Dehydroepiandrosterone (DHEA)IBA
10/2005 - 08/2003
2Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
07/2005 - 12/2003
2Interleukin-10 (Interleukin 10)IBA
06/2004 - 05/2004
2Prolactin Receptors (Prolactin Receptor)IBA
12/2003 - 05/2002
2ProgesteroneFDA LinkGeneric
07/2003 - 06/2003
1GlycogenIBA
10/2008
1Chemokine CCL3IBA
08/2008
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
08/2008
1Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
08/2008
1neutrophil cytosol factor 67KIBA
05/2008
1Protein Tyrosine PhosphatasesIBA
05/2008
1HormonesIBA
03/2008
1Mitogen-Activated Protein KinasesIBA
07/2007
1N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime (PUGNAC)IBA
04/2007
1GTP-Binding Proteins (G-Protein)IBA
04/2007
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
04/2007
1Caspase 3 (Caspase-3)IBA
03/2007
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2007
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
03/2007
1CytokinesIBA
02/2007
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2007
1Keratins (Keratin)IBA
01/2007
1Lidocaine (Xylocaine)FDA LinkGeneric
11/2006
1src-Family KinasesIBA
09/2006
1PPAR gammaIBA
07/2006
1Peroxisome ProliferatorsIBA
08/2005
1ProlactinIBA
05/2005
1OxygenIBA
02/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2004
1Dihydrotestosterone (Androstanolone)IBA
02/2004
1Testosterone (Sustanon)FDA LinkGeneric
07/2003
1NF-kappa B (NF-kB)IBA
10/2002
1adrenomedullin receptorIBA
04/2002
1Arginine (L-Arginine)FDA Link
01/2002

Therapy/Procedure

4Resuscitation
10/2008 - 03/2002
1Transplantation (Transplant Recipients)
12/2003